UI Hospitals and Clinics

Clinical Trial Details

Short Title
Official Title
Study Investigating the Effects of Risperidone, Paliperidone, or Abilify on Youth

A research study investigating the effects of Risperidone, Paliperidone, or Abilify on youth is being conducted at UIHC. A group of untreated participants is also invited.

Participants must:

  • Be between the 5-16 years old
  • Have just started taking Risperidone, Paliperidone, or Abilify within the last month OR not be taking any psychiatric medications
  • Be Medically Healthy
  • Other restrictions may apply

The visits will involve:

  • Questionnaires
  • Stool Samples
  • Blood tests
  • X-rays for bone scans

The child's psychiatric care will remain with their regular doctor throughout the study.

Compensation is available, including mileage reimbursement.

Start Date
June 19, 2013
End Date
December 19, 2013
Gender Preference
Age Group
5 - 15 years
Principal Investigator
Contact Info

Call: 319-335-7349

Abilify ; Paliperidone ; Psychiatry ; Risperidone ;

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.